Used in the synthesis of peptidomimetic drugs, particularly as an intermediate in developing enzyme inhibitors. Its chiral structure supports the design of biologically active compounds with high selectivity, especially in protease-targeted therapies. Commonly applied in pharmaceutical research for optimizing metabolic stability and binding affinity in peptide-based drug candidates.